title: Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
authors.forename: N
authors.initials: N
authors.lastname: Schleinitz
authors.forename: M
authors.initials: M
authors.lastname: Ebbo
authors.forename: K
authors.initials: K
authors.lastname: Mazodier
authors.forename: P
authors.initials: P
authors.lastname: Poullin
authors.forename: E
authors.initials: E
authors.lastname: Bernit
authors.forename: V
authors.initials: V
authors.lastname: Veit
authors.forename: A
authors.initials: A
authors.lastname: Veyradier
authors.forename: F
authors.initials: F
authors.lastname: Fakhouri
authors.forename: G
authors.initials: G
authors.lastname: Kaplanski
authors.forename: J-R
authors.initials: JR
authors.lastname: Harle
mesh_terms: D051722:ADAM Proteins / Q000276:immunology*; D000071120:ADAMTS13 Protein; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D010951:Plasma Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology / Q000628:therapy; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D000069283:Rituximab; D055502:Secondary Prevention
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D000069283:Rituximab; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human